Pharmaceutical sector: suspected anti-competitive agreements and conduct 50780

The CMA investigated alleged anti-competitive agreements and conduct in the pharmaceutical sector in relation to a generic drug under Chapters I and II CA98 and Articles 101 and 102 TFEU.

Case information

On 25 November 2019, the CMA closed the investigation on administrative priority grounds having considered the CMA’s prioritisation principles and the information available at the time. 

On 10 October 2017, the CMA launched the investigation under Chapters I and II of the CA98 and Articles 101 and 102 of the TFEU. The investigation related to alleged anti-competitive agreements and/or concerted practices and suspected abuse of dominance in relation to a generic pharmaceutical product.

Case reference: 50780

Case timetable

Date Action
November 2019 Investigation closed on administrative priority grounds
July 2018 to November 2019 CMA analysis and review of information gathered. Further investigation including further information requests
October 2017 to June 2018 Initial investigation and information gathering. CMA analysis and review of information gathered
October 2017 Investigation opened

Change log

The following changes have been made to the case timetable since it was first published in October 2017:

Date of change Reason for change Change made to timetable
19 April 2018 Additional time needed to gather and analyse information Date for completing initial investigation and information gathering changed from April 2018 to June 2018
18 January 2019 Additional time needed to gather and analyse additional information Date for completing information gathering and analysis changed from October 2018 to June 2019
18 June 2019 Additional time needed to gather and analyse information Date for completing initial investigation and information gathering changed from June 2019 to November 2019

Contacts

general.enquiries@cma.gov.uk

Published 13 October 2017
Last updated 26 November 2019 + show all updates
  1. Investigation closed on administrative priority grounds.

  2. Change log updated: Additional time needed to gather and analyse information.

  3. Case page updated to reflect the investigation into 2 different drugs (our case references: 50507.1 and 50507.2). An update to the case timetable has also been published.

  4. Case timetable updated.

  5. Case timetable updated.

  6. First published.